Landiolol

Rapibloc 300 mg poeder voor oplossing voor infusie

Poeder voor oplossing voor infusieNetherlandsAuthorisedAuthorised 16 Aug 2016

In other countries

The same active substances on other registers, the same brand first.

Rapibloc 300 MG Polvo Para Solucion Para PerfusionSpain · 300 mg · polvo para solución para perfusión · Orpha-Devel Handels Und Vertriebs GmbhSame brand
Rapibloc 20 mg/2 ml koncentrat za otopinu za injekcijuCroatia · koncentrat za otopinu za injekciju · Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, AustrijaSame brand
Rapibloc 300 mg prašak za otopinu za infuzijuCroatia · prašak za otopinu za infuziju · Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, AustrijaSame brand
RAPIBLOC 300 mgRomania · 300 mg · pulb. pt. sol. perf. · Anomed Pharma GMBHSame brand
LandioblocItaly · Concentrato per soluzione iniettabile · Amomed Pharma GMBHSame form
SibboranCanada · 300 MG / VIAL · Powder For Solution · Aop Orphan Pharmaceuticals GMBHSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Landiolol

Rapibloc 300 mg poeder voor oplossing voor infusie

Poeder voor oplossing voor infusieNetherlandsAuthorisedAuthorised 16 Aug 2016

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

RapiblykUnited States · 280MG BASE/VIAL · powder · Aop HLTH US

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Landiolol
Dosage form: Poeder voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 16 Aug 2016
Registration: 116682
Marketing authorisation holder: Amomed Pharma GmbH
ATC code: C07AB14
Group: Cardiovascular system
Procedure: National (RVG)
Supply: Uitsluitend recept

Netherlands